## Abstract ## Background Differentiated thyroid cancer (DTC) is among the most curable cancers. We evaluated the prognoses of patients with DTC from an iodineβdeficient area. ## Materials and Methods Four hundred twentyβtwo patients with thyroid cancer who underwent surgery between 1992 and 200
Prognosticators of survival in differentiated thyroid carcinoma
β Scribed by Hemen K. Parikh; Raja S. Rao; S. S. Shrikhande; Rohini Havaldar; Vinay H. Deshmane; Deepak M. Parikh
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 628 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0019-5421
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Approximately 20% of patients with thyroid carcinoma have relapse. To evaluate the factors affecting their disease-free survival and prognosis, we studied 68 patients with recurrent differentiated thyroid carcinoma, ranging in age from 5 to 73 years (mean: 47.6 years). Threefourths of pa
The overall prognosis of patients with differentiated thyroid cancer is excellent, but the prognosis is rapidly worsening, when the disease is diagnosed in elderly patients. Old patients more often present with poor prognostic features, such as large tumors, follicular or HΓΌrthle cell subtypes, extr